ODYSSEY MONO: effect of alirocumab 75 mg subcutaneously every 2 weeks as monotherapy versus ezetimibe over 24 weeks (Q39052365)
scientific article published on January 2015
Language:
(P31) (Q13442814)
(P304) 27-37
(P433) 1
(P478) 11
(P577) Thursday, January 1, 2015
(P1433) (Q15765184)
(P1476) "ODYSSEY MONO: effect of alirocumab 75 mg subcutaneously every 2 weeks as monotherapy versus ezetimibe over 24 weeks" (language: en)
(P2093) Eli M Roth
James M McKenney
(P2860) (Q28301815)
(Q38076875)
(Q34212424)
(Q45958080)
(Q27024882)
(Q34490730)
(Q28202519)
(Q29616310)
(Q24658039)
(Q38078264)
(Q34262650)
(Q44974421)
(Q38206839)
(Q34534248)
(Q37134467)
(Q34324688)
(Q57635512)
other details
description scientific article published on January 2015

External Links